Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT04166071
EARLY_PHASE1

Opioids and Social Support Enhanced Extinction Effects

Sponsor: University of California, Los Angeles

View on ClinicalTrials.gov

Summary

University of California, Los Angeles researchers will recruit healthy participants (age 18-35) to participate in a study examining whether the administration of naltrexone, an opioid antagonist, eliminates the ability of social support figure reminders to enhance fear extinction--a process during which a threatening cue is learned to not predict a negative or threatening outcome (i.e., electric shock) by being repeatedly presented in the absence of that outcome. After undergoing an email screening, a telephone screening, an in lab screening, and a health screening, 60 participants will be enrolled in the study. During the experiment, 30 participants will be administered naltrexone and 30 participants will be administered placebo (both participants and experimenters will be blind to condition) before undergoing a fear extinction procedure in which threatening cues--cues that predict electric shock--will be paired with either an image of a social support figure (provided by participants) or a second threatening cue. These pairings will be presented repeatedly in the absence of shock in order for fear extinction to occur. Participants will return for a follow-up test to determine if fear extinction was successful.

Official title: Revisiting Safety Signals: Examining a Separate Safety Mechanism for Social Support Figures

Key Details

Gender

All

Age Range

18 Years - 35 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2021-12-13

Completion Date

2026-09

Last Updated

2025-10-20

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Naltrexone

Half of the participants will be randomly assigned to take one dose of naltrexone (50mg, capsule form) during the experimental session

DRUG

Placebo

Half of the participants will be randomly assigned to take a placebo capsule during the experimental session

Locations (2)

UCLA Department of Psychology, 5514 Pritzker Hall

Los Angeles, California, United States

UCLA

Los Angeles, California, United States